o ka Naauao
ʻO ka maʻi ʻaʻai umauma metastatic ka maʻi ʻaʻai holomua i pāhola ʻia i nā ʻāpana ʻē aʻe o ke kino ma ʻō aku o ka umauma o ka umauma, a he wānana maikaʻi ʻole loa. ʻO ka mālama ʻana no ka neoplasm malignant umauma metastatic e neʻe nei i ka pilikino pilikino e pili ana i nā ʻano maʻi ʻaʻai. ʻO nā ʻōlelo pilikino pilikino like (nā meaʻai a me nā mea kōkua) e pili ana i nā ʻano maʻi ʻaʻai a me ka mālama ʻana e nele a pono nui ʻia e hoʻomaikaʻi i nā kūleʻa o ka kūleʻa a me ke ʻano o ke ola o ka mea maʻi maʻi. Kuhi kēia blog i nā pono, nā hemahema a me nā laʻana o ka pilikino pilikino / meaʻai (meaʻai a me nā mea kōkua) no ka maʻi ʻaʻai umauma metastatic.
Nā Kumua o ka maʻi ʻaʻai umauma
ʻO ka maʻi ʻaʻai umauma ka maʻi ʻaʻai ʻike pinepine ʻia a ʻo kekahi o nā kumu kumu o ka make ʻana e pili ana i ka maʻi ʻaʻai i nā wahine ma ka honua holoʻokoʻa. ʻO kekahi o nā subtypes maʻamau o ka maʻi ʻaʻai umauma ka mea pili i ka hormone sex, estrogen (ER) a me ka progesterone (PR) reseptor maikaʻi a me nā mea ulu ulu epidermal kanaka 2 (ERBB2, i kapa ʻia ʻo HER2) maikaʻi ʻole - (ER + / PR + / HER2- subtype). He wānana maikaʻi ka hormone subtype maikaʻi o ka maʻi ʻaʻai umauma me kahi helu ola kiʻekiʻe he 5 mau makahiki loa o 94-99% (ʻO Waks a me Lanakila, JAMA, 2019). ʻO nā ʻano ʻē aʻe o ka umauma Ka maʻi 'aʻai ʻO ia ka ʻano ʻano ʻano ʻino ʻole o ka hormone receptor, HER2 maikaʻi a me ka triple negative breast cancer (TNBC) subtype ʻo ia ka ER, PR a me HER2 ʻino. Loaʻa i ka subtype TNBC ka wānana ʻino loa a me ke kūlana kiʻekiʻe loa o ka neʻe ʻana i ka maʻi hope loa i hoʻonui ʻia a laha i nā wahi ʻē aʻe o ke kino.
ʻO ka maʻi maʻi Metastatic Breast Cancer ka holomua loa, pae IV maʻi ʻaʻai i hohola ʻia i nā ʻāpana ʻē aʻe o ke kino (ʻo ka pinepine, nā iwi, nā akemāmā, ka ate a me ka lolo). Aia he 6% wale nō o nā wahine i ʻike ʻia me ka neoplasm malignant umauma metastatic i ka ʻike mua. ʻO ka hapa nui o nā hihia ʻē aʻe o ka neoplasm maʻi hānai a me metastatic i ka wā i hoʻi hou ai ka maʻi ʻaʻai i ka mea maʻi ma hope o ka pau ʻana o ka lapaʻau mua a me ke kala ʻia no nā makahiki he nui. ʻO ka maʻi ʻaʻai umauma metastatic, ka hapanui o nā wahine akā ʻike ʻia nō hoʻi i kahi pākēneka liʻiliʻi o nā kāne, loaʻa kahi wānana maikaʻi loa me kahi ola 5 mau makahiki ma lalo o 30% e like me ka ʻike mai ka American Cancer Society Publication (Cancer Facts and Figures, 2019 ). ʻO ke ola waena waena o ka metastatic TNBC he 1 makahiki wale nō ke hoʻohālikelike ʻia me 5 mau makahiki no nā ʻano subtypes ʻelua. (ʻO Waks AG a me Winer EP, JAMA 2019)
Nā koho lapaʻau no ka maʻi ʻaʻai Metastatic umauma
Mālama ʻia ka maʻi ʻaʻai umauma metastatic me nā regimens lapaʻau like ʻole e like me nā papa like ʻole o ka chemotherapy, immunotherapy, hoʻomōhala hoʻomōhala, hormonal therapy a ke kauwela nā koho, ma o ka hoʻāʻo ʻana a me ke kaʻina hana hewa, no ka mea ʻaʻohe wehewehe pono ʻia no kēia maʻi ʻaʻai. ʻO ke koho ʻana e pili i nā mole mole o nā hunaola maʻi ʻaʻai o ka umauma, nā maʻi maʻi ʻaʻai o ka umauma i hala, ke kūlana olakino o ka mea maʻi a me kahi i laha ai ka maʻi ʻaʻai.
Inā ua pālahalaha ka maʻi ʻaʻai o ka umauma i nā iwi, a laila me ka endocrine therapy, chemotherapy a i ʻole hoʻomōhala hoʻomōhala ʻia, mālama pū ʻia ka mea hoʻomanawanui me nā mea hoʻololi hoʻololi iwi e like me bisphosphonates. Kōkua kēia mau mea me ka mālama palliative akā ʻaʻole i hōʻike ʻia e hoʻomaikaʻi i ke ola holoʻokoʻa.
Inā ua holomua ka maʻi ʻaʻai umauma maikaʻi i ka maʻi metastatic pae IV, mālama ʻia nā mea maʻi me ka endocrine therapy i hoʻonui ʻia me nā ʻākena e modulate a pāpā paha i nā mea loaʻa estrogen, a pale paha i ka hana ʻana o ka estrogen i ke kino. Hoʻohana ʻia ka endocrine therapy, inā maikaʻi ʻole, me ka launa pū me nā lāʻau chemotherapy a i ʻole nā lāʻau i manaʻo ʻia e like me nā kaola uila kinase inhibitors a i ʻole nā lāʻau e kuhikuhi ana i nā wahi kikoʻī kikoʻī kūloko, e pili ana i ka molekole a me nā genomic ʻano o ka maʻi ʻaʻai.
No ka maikaʻi ʻole o ka hormone, HER2 maikaʻi, ka maʻi ʻaʻai umauma metastatic, kahi koho lapaʻau nui ʻo ia ka HER2 i hoʻomoʻa ʻia i nā lāʻau ʻohola antibody a i ʻole nā mea hoʻopale mole liʻiliʻi. Hoʻohui ʻia kēia mau mea me nā lāʻau chemotherapy ʻē aʻe.
Eia nō naʻe, no nā maʻi maʻi metastatic TNBC me ka wānana maikaʻi ʻole, ʻaʻohe o nā koho lapaʻau i wehewehe ʻia. Hoʻokumu ʻia ia i ke alo o nā hoʻololi nui ʻē aʻe i kēia subtype o ka maʻi ʻaʻai. I ke ʻano o nā maʻi ʻaʻai BRCA mutant, mālama ʻia lākou me nā mea hoʻopuka poly-ADP ribose (PARP). Inā loaʻa i kēia mau maʻi ʻākoʻikoʻi nā kikoʻī pale, hiki iā lākou ke mālama ʻia me nā lāʻau immunotherapy e like me nā mea hoʻopaneʻe pale pale pale. ʻĒ aʻe, mālama ʻia kēia mau mea maʻi me nā koho chemotherapy hōʻeuʻeu loa e like me nā lāʻau platinum (Cisplatin, Carboplatin), adriamycin (Doxorubicin), nā lāʻau ʻauhau (Paclitaxel), nā mea hoʻokipa topoisomerase (Irinotecan, Etoposide) a me nā ʻano mea like ʻole like ʻole o kēia mau mea, e kāohi ka laha ana o ka mai. Hoʻohana ʻia ka chemotherapy no ka hoʻomaʻamaʻa ʻana i ka maʻi ʻaʻai umauma metastatic akā nui loa ka ʻona a me kahi hopena maikaʻi ʻole i ka maikaʻi o nā ola.
Pono no nā ʻōlelo aʻoaʻo pilikino pilikino no nā maʻi maʻi maʻi
ʻO kahi hōʻailona maʻi ʻaʻai iā ia iho kahi hanana hoʻololi e pili ana me ka hopohopo no ka huakaʻi lapaʻau e hiki mai ana a me ka makaʻu i ka maopopo ʻole o ka hopena. Ma hope o ka ʻike ʻia me ka maʻi ʻaʻai, hoʻonāukiuki ʻia nā mea maʻi e hana i nā loli ke ola i manaʻo ʻia e hoʻomaikaʻi i ko lākou olakino a me ko lākou olakino, hoʻemi i ka weliweli o ka hoʻi hou ʻana, a hoʻemi i nā hopena ʻaoʻao o kā lākou lapaʻau chemotherapy. I ka manawa pinepine, hoʻomaka lākou i ka hoʻohana ʻana i nā mea hoʻopiha papaʻai me ka lōkahi, me kā lākou mālama ʻana i ka chemotherapy, e kōkua ai i ka hōʻemi ʻana i nā hopena ʻino loa a hoʻomaikaʻi i ko lākou olakino olakino. Aia nā hōʻike o 67-87% o nā maʻi maʻi ʻaʻai e hoʻohana i nā mea hoʻopihapiha diet post post diagnosis. (ʻO Velicer CM et al, J Clin. ʻO Oncol., 2008)
Eia naʻe, ʻaʻohe pilikino nā ʻōlelo hānai a me nā papaʻai no nā mea maʻi ʻaʻai i kēia lā. ʻOiai nā holomua o nā genomics, metabolomics, proteomics i hoʻomaikaʻi i ko mākou ʻike i nā ʻano maʻi ʻaʻai a me ka hiki ʻana i ke ʻano o ka hoʻomaʻemaʻe ʻana, ke alakaʻi ʻana i ka meaʻai inā he mana nui kekahi. ʻAʻole hoʻokumu ʻia ke alakaʻi meaʻai i ke ʻano maʻi ʻaʻai kikoʻī a me nā ʻano genetiko o ka maʻi ʻaʻai, a i ʻole ke ʻano o ka lāʻau i hāʻawi ʻia i ka mea maʻi. ʻO nā kulekele laulā no ka meaʻai / papaʻai e like me ka ʻōlelo a ka American Cancer Society e komo pū ana:
- Mālama i kahi kaupaona olakino;
- Hāpai i kahi nohona ola kino;
- Ke hoʻopau nei i ka papaʻai olakino me ke koʻikoʻi i nā kumuwaiwai mea kanu; a
- Ka palena ʻana i ka inu lama.
ʻO nā koho lapaʻau no nā maʻi ʻokoʻa ʻokoʻa i hōʻike ʻia a koi ʻia e nā ʻōkuhi kaiāulu like ʻole e like me ka National Comprehensive Cancer Network (NCCN) a i ʻole American Cancer Society (ACS). Hoʻokumu ʻia nā hōʻike i loaʻa no nā lāʻau i nā hoʻokolohua hoʻokolohua kaulike nui ʻia (RCTs). Hoʻonohonoho ʻia nā ʻano lapaʻau he nui i nā ʻano genomic maʻi ʻaʻai. ʻOiai kēlā, no ka nui o nā maʻi ʻaʻai e like me ka metastatic TNBC, ʻaʻohe alakaʻi maʻamau a me nā regimens lapaʻau e ʻike ʻia he maikaʻi. Hoʻomau ʻia ka mālama ʻana no kēia subtype i ka hoʻokolokolo a me nā hoʻokokoke hewa.
Eia nō naʻe, ʻaʻohe mea e pili ana i nā kulekele e pili ana i ka pilikino / nā papaʻai pilikino. Aia ka hapa o nā RCT e hana i nā hōʻike no ka hoʻomohala ʻana i nā ʻōlelo ʻaiaola a me nā alakaʻi papaʻai e hoʻopiha ai i nā ʻano maʻi ʻaʻai like ʻole a me nā mālama ʻana. He āpau nui kēia a mākou e mālama nei i ka maʻi ʻaʻai i kēia lā. I loko nō o ka hoʻonui ʻana o ka ʻike o ka pilina o nā ʻenekua, ʻo nā paʻakikī o nā hana nutrient a me nā pilina e paʻakikī e kamaʻilio kūpono ma o ka hoʻolālā noiʻi RCT hoʻokahi. (Blumberg J et al, Nutr. Rev, 2010)
Ma muli o kēia palena, ʻokoʻa mau ka pae o ka hōʻike no ke kākoʻo ʻana i ka meaʻai a me ka hilinaʻi no ka wehewehe ʻana i nā pono meaʻai / meaʻai no nā maʻi maʻi maʻi maʻi mai ka mea e pono ai no ka loiloi lāʻau. Eia hou, ʻo ke alakaʻi ʻana i ka meaʻai/ʻai ʻaʻole e like me nā lāʻau lapaʻau he kūlohelohe, palekana a pili pū me nā hopena haʻahaʻa a liʻiliʻi i ka hapa nui o nā hihia. Eia naʻe, hoʻopilikino i nā ʻōlelo aʻoaʻo meaʻai no ka pōʻaiapili kikoʻī o Ka maʻi 'aʻai ʻano a me ka lapaʻau e pili ana i ke ala ʻepekema a me kahi kumu i kākoʻo ʻia e ka ʻikepili hoʻokolohua, ʻoiai ʻaʻole like me nā hōʻike i hoʻokumu ʻia RCT, hiki ke hāʻawi i ke alakaʻi maikaʻi aʻe no nā maʻi a hoʻonui i ka mālama ʻana i ka maʻi kanesa.
ʻOiai he heterogeneity ʻoiai i nā maʻi ʻino a me nā mālama ʻana no nā neoplasms malignant metastatic o ka ʻano kiko like, pono e hoʻopilikino ʻia i nā ʻōlelo ʻaiaola. ʻO ka meaʻai kūpono kūpono a me nā mea nui aku e hōʻalo i nā ʻano kikoʻī a i ka wā o ka mālama ʻana hiki ke kōkua i ka hoʻomaikaʻi ʻana i nā hopena.
Nā Mea ʻai e ʻAi ai Ma hope o ka ʻike maʻi ʻaʻai!
ʻAʻohe ʻelua maʻi ʻaʻai. E hele i waho o nā kulekele meaʻai maʻamau no kēlā me kēia kanaka a hoʻoholo i nā koho pilikino e pili ana i ka meaʻai a me nā mea hoʻopihapiha me ka hilinaʻi.
Nā kōkua o ke kōkua pilikino pilikino / papaʻai (nā meaʻai a me nā mea kōkua) no ka maʻi ʻaʻai Metastatic umauma
E like me nā ʻano maʻi a me nā mālama ʻana no ka maʻi ʻaʻai umauma metastatic i loli loa e pili ana i ka subtype mua o ka maʻi, ʻaʻole nō e like ka nui o nā koi no ke kākoʻo pono / meaʻai (nā meaʻai a me nā mea hoʻopiha). E kaukaʻi ʻia ia i nā ʻano genetiko o ka maʻi ʻaʻai umauma metastatic a me ke ʻano o ka mālama ʻana i loaʻa. No laila nā kumu kūlohelohe o ka maʻi, nā ʻano ʻē aʻe o nā mea maʻi pākahi e pili ana i ka papa kuhikuhi o ko lākou kino (BMI) e nānā i nā pae momona, nā ʻano nohona e like me ka hoʻoikaika kino, ka ʻona ʻana a me nā mea ʻē aʻe e lilo i mea nui i ka hoʻolālā ʻana i ka pilikino. hiki ke kākoʻo a kūpono i ka hoʻohaunaele ʻana i ka maʻi ʻaʻai i kēlā me kēia pae o ka maʻi.
ʻO ka mea nui o ka hāʻawi ʻana i nā meaʻai pilikino / alakaʻi pilikino i hoʻonohonoho ʻia i ka maʻi ʻaʻai kikoʻī a me ka mālama ʻana, no nā mea maʻi me nā neoplasms malignant umauma metastatic hiki ke hāʻawi i nā pono aʻe: (Wallace TC ma, J. o Amer. ʻO Coll o Nutr., 2019)
- Hoʻonui i ka ikaika a me ka palekana o ka mea hoʻomanawanui me ka ʻole o ka hoʻopilikia ʻana i ka pono o ka lāʻau.
- Kōkua me ka hoʻēmi ʻana i nā ʻaoʻao a me nā hopena.
- Kōkua me ka hoʻomaikaʻi ʻana i ka hopena o ka hoʻomaʻamaʻa mau e ke koho ʻana i nā meaʻai a me nā mea hoʻopihapiha i hiki ke synergize me ke ʻano hana o ka hana hoʻomau ʻana ma o ka modulate ʻana i nā ala kūpono, a i ʻole ka pāpā ʻana i nā ala kūʻē kūʻē.
- Hōʻalo i nā meaʻai a me nā mea hoʻopihapiha i hiki ke hoʻopilikia i ka mālama mau ʻana ma o ka launa ʻana o ka lāʻau nutrient i hiki ke hoʻohaʻahaʻa i ka hopena a hoʻonui paha i ka lāʻau o ka lāʻau.
Nā laʻana o ka pilikino pilikino / Meaʻai (Meaʻai a me nā Mea Hoʻohui) no Metastatic umauma Ka maʻi ʻaʻai
ʻO nā papaʻai / meaʻai (nā meaʻai a me nā mea hoʻopiha) nā ʻōlelo aʻoaʻo no ka metastatic hormone maikaʻi maʻi maʻi ʻaʻai e hoʻomau i ka endocrine therapy e like me Tamoxifen e ʻokoʻa loa ia mai nā mea maʻi maʻi umauma metastatic umauma maʻi.
Nā laʻana o nā meaʻai / Pākuʻi e hōʻalo inā ma ka mālama ʻana me nā Estrogen Modulator
No nā mea maʻi ma nā modulator estrogen, kekahi mau laʻana o nā meaʻai a me nā mea hoʻopihapiha e pono ai lākou e hōʻalo i hiki ke hoʻopilikia i kā lākou mālama endocrine a me nā kumu ʻepekema i ʻōlelo ʻia ma lalo:
Curcumin
Curcumin, ka mea hana mai ka curry spice turmeric, kahi mea kōkua kūlohelohe i kaulana i waena o nā mea maʻi ʻaʻai a me nā mea ola no kāna kūʻē i ke kanesa a me nā anti-inflammatory waiwai. No laila, ʻo ka likelihood o nā mea maʻi maʻi umauma e lawe nei iā Curcumin ʻoiai kiʻekiʻe ʻo Tamoxifen therapy.
Hoʻopili ʻia ka lāʻau oral Tamoxifen i loko o ke kino i loko o nā metabolite hana lāʻau ma o ka cytochrome P450 enzymes i ke akepaʻa. ʻO Endoxifen ka metabolite hana ʻo Tamoxifen, ʻo ia ka mea nui waena o ka pono o tamoxifen therapy (ʻO Del Re M et al, ʻo Pharmacol Res., 2016). Ua hōʻike ʻia kahi noiʻi noiʻi prospective prospective (EudraCT 2016-004008-71 / NTR6149) mai ka Erasmus MC Cancer Institute ma Netherlands, ua hōʻike i kahi pilina maikaʻi ʻole ma waena o Curcumin a me Tamoxifen i nā maʻi maʻi maʻi hānai (Hussaarts KGAM et al, Nā maʻi ʻaʻai (Basel), 2019). Ua hōʻike nā hopena i ka hoʻoliʻiliʻi o ka metabolite hana Endoxifen i hōʻemi ʻia i kahi ʻano helu i ka wā i lawe ʻia ai ʻo Tamoxifen me Curcumin supplement.
ʻAʻole hiki ke mālama ʻia nā haʻawina e like me kēia, ʻoiai ma kahi helu liʻiliʻi o ka umauma Ka maʻi 'aʻai nā mea maʻi, a hāʻawi i kahi akahele no nā wahine e lawe ana i ka tamoxifen e koho i nā mea hoʻohui kūlohelohe a lākou e lawe pono ai, ʻaʻole e hoʻopilikia i ka hopena o ka lāʻau maʻi maʻi ma kekahi ʻano. Ma muli o kēia hōʻike, ʻaʻole ʻo Curcumin ka mea hoʻohui kūpono e lawe pū me Tamoxifen. Akā naʻe, ʻaʻole kēia manaʻo e pale loa ʻia ka curcumin ma ke ʻano he mea ʻala a me ka mea ʻono i ka curries.
DIM (diindolylmethane) Pākuʻi
ʻO kahi mea kōkua maʻamau a hoʻohana pinepine ʻia i waena o nā mea maʻi maʻi umauma ʻo DIM (diindolylmethane), kahi metabolite o I3C (Indole-3-carbinol), i loaʻa ma lāʻau lau e like me broccoli, cauliflower, kale, cabbage, brussel sprouts. Hiki ke hoʻokumu ʻia kēia kaulana o DIM ma nā noiʻi haukapila i hōʻike ʻia i ka hoʻohana nui ʻana o nā mea kanu kolio i loko o ka papaʻai / mea hānai e pili nui me ka 15% haʻahaʻa o ka maʻi ʻaʻai umauma. (Liu X et al, umauma, 2013) Eia nō naʻe, kahi randomized, blind-blind, placebo kāohi hoʻokolohua hoʻopaʻa haʻawina i hoʻāʻo i ka hoʻohana o Pākuʻi DIM me Tamoxifen i nā maʻi maʻi ʻaʻai umauma, ua hōʻike i ke ʻano weliweli o ka tamoxifen hana metabolite hoʻemi ʻana, a laila hiki i ka hiki ke hōʻemi i ka hopena o ka endocrine therapy. (NCT01391689) (Thomson CA, Breast Cancer Res. Hana., 2017).
ʻOiai ke hōʻike nei nā ʻike maʻi i ke ʻano o ka launa pū ma waena o DIM a me tamoxifen, ʻo nā mea maʻi maʻi umauma ʻoiai ʻo tamoxifen therapy e hele ma ka ʻaoʻao o ke akahele a hōʻole i ka lawe ʻana i ka waihona DIM. ʻO kahi papaʻai mea kanu mea ʻai i waiwai i nā mea kanu kolio hiki ke hāʻawi i ka pono e pono ai ma mua o ka lawe ʻana i kahi waihona o DIM i kēia ʻano.
ʻO nā meaʻai kūpono a makemake ʻia no ka maʻi hānai Metastatic Breast
Nui nā meaʻai a me nā mea hoʻopili e pili ana me ka hoʻomaikaʻi ʻana i nā hopena no nā mea maʻi maʻi umauma metastatic. Ua hōʻike ʻia kahi meta-analysis o nā noiʻi prospective he nui a me nā RCT e nā mea noiʻi mai Institut Curie i Palani e pili ana kahi papaʻai momona momona me ke ola ʻoi aku ka maikaʻi. Eia kekahi, kahi papaʻai i waiwai i nā mea hoʻomaʻemaʻe kino mai nā huaʻai a me nā mea kanu, hoʻemi i ka makaʻu o ke kanesa hou. A, ʻo ka papaʻai olakino me nā meaʻai mea kanu e pili ana me ka hoʻomaikaʻi ʻana i ke ola āpau a me ka makaʻu o ka make. (Maumy L et al, Ka maʻi ʻaʻai kau, 2020)
ʻO kahi noiʻi i paʻi ʻia ma mua o kēia makahiki i hoʻāʻo i ka hopena o kaʻai ketogenic / meaʻai i ke ola o nā maʻi maʻi maʻi umauma. Ua ʻike lākou i kaʻai ketogenic me nā chemotherapy hoʻomau e hoʻomaikaʻi i ke ola holoʻokoʻa me ka ʻole o nā hopena ʻē aʻe i nā maʻi. (Khodabakhshi A, Nutr. Kanesa, 2020) ʻO kaʻai ketogenike kahi papaʻai low-carbohydrate nui loa e manaʻo e hāpai i ka metabolism o nā momona i loko o nā kino ketone (ma mua o nā carbohydrates i ka glucose) e hāʻawi i ke kumu nui o ka ikehu no ke kino. Hiki i nā hunaola maʻamau i loko o kā mākou kino ke hoʻololi i ka hoʻohana ʻana i nā kino ketone no ka ikehu, akā ʻaʻole hiki i nā hunaola maʻi ʻaʻai ke hoʻohana pono i nā kino ketone no ka ikehu ma muli o kahi metabolism tumo maʻamau. ʻO kēia ka mea e maʻalahi ai nā hunaola tumora a ʻo ka mea hoʻohui, hoʻemi ke kino ketone i ka angiogenesis tumo a me ka mumū ʻoiai e hoʻonui ana i ka make o ka pūpū tumora. (Wallace TC ma, J. o Amer. ʻO Coll o Nutr., 2019)
No ka mea pono e kau ʻia nā pahuhopu therapeutic kikoʻī e pili ana i nā ʻano maʻi ʻaʻai a me ke ʻano o ka mālama ʻana, pono e hoʻokumu ʻia ka kikoʻī a me ka pilikino pilikino ma luna o kēlā me kēia meaʻai a me nā mea hoʻopihapiha me nā ʻano hana o ka hana ma ka pae mole mole e pili ana i nā hopena ma nā genes a me nā ala hele. (ʻO Reglero C a me Reglero G, Nutrients, 2019)
ʻO kahi laʻana, hoʻokahi ala e pale aku ai i ka metastasis o ka maʻi ʻaʻai ka pale ʻana i ka angiogenesis, ke kupu ʻana o nā kīʻaha koko hou, kahi e pale ai i ke kūpaʻa chemotherapy. Aia nā meaʻai a me nā mea hoʻohui me ka bioactive silibinin, e like me artichoke a waiū waiū, i hōʻike ʻepekema e kāohi i ka angiogenesis. Nā ʻōlelo aʻoaʻo pilikino / papaʻai pilikino o kēia mau meaʻai / mea hoʻopiha i kēia ʻano o ka maʻi ʻaʻai umauma metastatic e hele ana i ka chemotherapy, hiki ke kōkua i ka hoʻomaikaʻi ʻana i ka maikaʻi o ka mālama ʻana a pale i ka hoʻi hou ʻana. (Binienda A, et al, Nā Anticancer Agents Med Chem, 2019)
Pēlā nō, hiki ke kālailai ʻia nā ʻano kī ʻē aʻe o ka maʻi ʻaʻai a me ka mālama ʻana e ʻike i nā meaʻai kūpono ʻepekema a me nā mea hoʻopihapiha no ka hoʻolālā pilikino pilikino no nā mea maʻi maʻi maʻi e kūlike i kā lākou ʻano maʻi ʻaʻai e like me ka maʻi ʻaʻai umauma metastatic a me ka mālama ʻana.
Panina
Ke neʻe nei nā manaʻo lapaʻau i ka pilikino e pili ana i ka genomics cancer a me nā hiʻohiʻona molecular cancer o kēlā me kēia maʻi, pono pū ka mālama ʻana i ka maʻi maʻi e neʻe i ka meaʻai kākoʻo pilikino e pili ana i ke kahua a me ke ʻano o Ka maʻi 'aʻai a me ka lapaau ana. He wahi nui ʻole kēia i hiki ke kōkua nui i ka hoʻomaikaʻi ʻana i nā hopena a me ka maikaʻi o ke ola no nā poʻe maʻi me ka maʻi kanesa umauma metastatic. I ke olakino maikaʻi, ʻaʻohe pōʻino nā meaʻai maoli a me nā mea hoʻohui. Akā, inā ʻo ka pōʻaiapili ka maʻi kanesa kahi e hana mua ai ke kino i kahi dysregulation kūloko i ka metabolism a me ka pale ʻana ma muli o ka maʻi a me ka mālama mau ʻana, ʻo nā meaʻai maoli, inā. koho pono ʻole ʻia, hiki ke hana i ka ʻino. No laila, nā meaʻai pilikino pilikino e pili ana i ka maʻi ʻaʻai (e like me ka maʻi ʻaʻai o ka umauma) a me ke ʻano lapaʻau e hiki ke kākoʻo i nā hopena i hoʻomaikaʻi ʻia a me ka maikaʻi no ka mea maʻi.
He aha nā meaʻai āu e ʻai ai a me nā mea hoʻopihapiha āu e lawe ai i hoʻoholo. Pono e hoʻoholo i kāu hoʻoholo ʻana e pili ana i ka hoʻololi ʻana i nā ʻāpana o ka maʻi ʻaʻai, ka maʻi ʻaʻai, nā lāʻau e hoʻomau nei a me nā mea hoʻopihapiha, nā maʻi āpau, nā ʻike nohona, ke kaupaona, ke kiʻekiʻe a me nā ʻano.
ʻAʻole hoʻokumu ʻia ka hoʻolālā meaʻai no ka maʻi ʻaʻai mai addon ma ka ʻimi pūnaewele. Hoʻokele ia i ka hoʻoholo ʻana iā ʻoe ma muli o ka ʻepekema molekole i hoʻokō ʻia e ko mākou ʻepekema a me nā ʻenekini polokalamu. Nānā ʻole inā ʻoe e noʻonoʻo e hoʻomaopopo i ke ʻano o nā ʻolaola biōmika kumu a i ʻole ʻole - no ka hoʻolālā meaʻai no ka maʻi ʻaʻai e pono ai ka ʻike.
E hoʻomaka I K NOWIA manawa me kāu hoʻolālā meaʻai e ka pane ʻana i nā nīnau e pili ana i ka inoa o ka maʻi ʻaʻai, ka hoʻololi ʻana o nā kūpuna, nā mālama ʻana a me nā mea hoʻopihapiha mau, nā maʻi āpau, nā ʻano, ka nohona, nā makahiki a me nā kāne.
Mea 'ai pilikino no ka ma'i 'a'ai!
Hoʻololi ka maʻi kanesa me ka manawa. Hoʻopilikino a hoʻololi i kāu meaʻai e pili ana i ka hōʻailona maʻi maʻi, ka mālama ʻana, ke ʻano o ka nohona, nā makemake meaʻai, nā allergies a me nā mea ʻē aʻe.
ʻO nā mea maʻi maʻi maʻi e hana pinepine me nā mea ʻokoʻa nā hopena ʻaoʻao chemotherapy kahi e hoʻopili ai i ko lākou ola o ke ola a nānā i nā hoʻoponopono ʻokoʻa no ka maʻi ʻaʻai. Lawe ana i ka ka meaʻai kūpono a me nā mea hoʻopihapiha e pili ana i nā noʻonoʻo ʻepekema (ka hōʻalo ʻana i ka wānana a me ke koho wale ʻana) ʻo ia ka lāʻau kūlohelohe maikaʻi loa no ka maʻi ʻaʻai a me ka lāʻau e pili ana ʻaoʻao-hopenats.